Esperion Therapeutics, Inc.

ESPR · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$144,761$82,248$124,775$208,892
Short-Term Investments$0$0$42,086$50,441
Receivables$80,142$48,494$33,729$22,934
Inventory$94,491$65,623$35,201$34,394
Other Curr. Assets$18,604$4,700$10,892$12,311
Total Curr. Assets$337,998$201,065$246,683$328,972
Property Plant & Equip (Net)$5,767$4,675$1,200$2,562
Goodwill$0$0$0$0
Intangibles$56$56$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$0$0$0$50,000
Total NC Assets$5,823$4,731$1,256$52,618
Other Assets$0$0$0$0
Total Assets$343,821$205,796$247,939$381,590
Liabilities
Payables$51,650$31,718$23,040$17,559
Short-Term Debt$104,902$36,381$384$1,392
Tax Payable$0$0$0$0
Deferred Revenue$8,518$25,402$3,507$5,683
Other Curr. Liab.$81,163$62,723$65,377$48,718
Total Curr. Liab.$246,233$156,224$92,308$73,352
LT Debt$486,310$504,566$260,564$258,804
Deferred Rev, NC$0$0$0$634
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$218,845$245,744
Total NC Liab.$486,310$504,566$479,409$505,182
Other Liabilities$0$0$0$0
Cap. Leases$5,311$4,573$1,049$1,916
Total Liabilities$732,543$660,790$571,717$578,534
Equity
Pref Stock$0$0$0$0
Common Stock$196$118$75$61
Retained Earnings-$1,601,029-$1,549,284-$1,340,036-$1,106,377
AOCI$0$0-$2-$31
Other Equity$1,212,111$1,094,172$1,016,185$909,403
Total Equity-$388,722-$454,994-$323,778-$196,944
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$343,821$205,796$247,939$381,590
Net Debt$446,451$458,699$136,173$51,304